SCOPUS 정보 검색 플랫폼

Volumn 125, Issue 1, 2012, Pages 70-74

Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer

(7) Xu, Jian Lun a Commins, John b Partridge, Edward c Riley, Thomas L b Prorok, Philip C a Johnson, Christine C d Buys, Saundra S e

a NATIONAL CANCER INSTITUTE (United States)

b INFORMATION MANAGEMENT SERVICES INC (United States)

c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE (United States)

d HENRY FORD HEALTH SYSTEM (United States)

e UNIVERSITY OF UTAH (United States)

Author keywords

CA 125; Ovarian cancer; Screening; Velocity

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CALIBRATION; CANCER CLASSIFICATION; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVARY CANCER; PREDICTION; PRIORITY JOURNAL;

AGED; CA-125 ANTIGEN; DATA INTERPRETATION, STATISTICAL; EARLY DETECTION OF CANCER; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84862783704 PISSN: 00908258 EISSN: 10956859 Source Type: Journal
DOI: 10.1016/j.ygyno.2011.12.440 Document Type: Article

Times cited : (17)

References (27)

1
- 0029639032
- National Institutes of Health Consensus Conference: Ovarian cancer, screening, treatment and follow-up
- National Institutes Of Health Consensus Development Panel On Ovarian Cancer
- National Institutes of Health Consensus Development Panel on Ovarian Cancer National Institutes of Health Consensus Conference: ovarian cancer, screening, treatment and follow-up JAMA 273 1995 491 497
- (1995) JAMA , vol.273 , pp. 491-497

2
- 0037404173
- Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: A preliminary investigation
- DOI 10.1016/S0090-8258(03)00051-9
- J.L. Wilder, E. Pavlik, J.M. Straughn, T. Kirby, R.V. Higgins, and P.D. DePriest Clinical implications of a rising serum CA-125 with the normal range in patients with epithelial ovarian cancer: a preliminary investigation Gynecol Oncol 89 2003 233 235 (Pubitemid 36457870)
- (2003) Gynecologic Oncology , vol.89 , Issue.2 , pp. 233-235
- Wilder, J.L.¹ Pavlik, E.² Straughn, J.M.³ Kirby, T.⁴ Higgins, R.V.⁵ DePriest, P.D.⁶ Ueland, F.R.⁷ Kryscio, R.J.⁸ Whitley, R.J.⁹ Van Nagell, J.¹⁰

3
- 0029068394
- Serum half-life of CA-125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: Results of a multicentric Italian study
- A. Gadducci, P. Zola, F. Landoi, T. Maggino, E. Sartori, and T. Bergamino Serum half-life of CA-125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study Gynecol Oncol 58 1995 42 47
- (1995) Gynecol Oncol , vol.58 , pp. 42-47
- Gadducci, A.¹ Zola, P.² Landoi, F.³ Maggino, T.⁴ Sartori, E.⁵ Bergamino, T.⁶

4
- 0025046911
- Early serum CA125 response and outcome in epithelial ovarian cancer
- DOI 10.1016/0277-5379(90)90085-8
- C.W. Redman, G.R. Blackledge, K. Kelly, J. Powell, E.J. Buxton, and D.M. Luesley Early serum CA-125 response and outcome in epithelial ovarian cancer Eur J Cancer 26 1990 593 596 (Pubitemid 20259337)
- (1990) European Journal of Cancer , vol.26 , Issue.5 , pp. 593-596
- Redman, C.W.E.¹ Blackledge, G.R.² Kelly, K.³ Powell, J.⁴ Buxton, E.J.⁵ Luesley, D.M.⁶

5
- 0026705372
- The prognostic implications of low serum CA-125 levels prior to the second-look operations for Stage III and IV epithelial ovarian cancer
- H.H. Gallion, J.E. Hunter, J.R. van Nagell, H.E. Averette, J.M. Cain, and L.J. Copeland The prognostic implications of low serum CA-125 levels prior to the second-look operations for Stage III and IV epithelial ovarian cancer Gynecol Oncol 46 1992 29 32
- (1992) Gynecol Oncol , vol.46 , pp. 29-32
- Gallion, H.H.¹ Hunter, J.E.² Van Nagell, J.R.³ Averette, H.E.⁴ Cain, J.M.⁵ Copeland, L.J.⁶

6
- 50349100794
- The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian cancer (PLCO) screening trial
- C.C. Johnson, B. Kessel, T.L. Riley, L.R. Ragard, C.R. Williams, and J.-L. Xu The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian cancer (PLCO) screening trial Gynecol Oncol 110 2008 383 389
- (2008) Gynecol Oncol , vol.110 , pp. 383-389
- Johnson, C.C.¹ Kessel, B.² Riley, T.L.³ Ragard, L.R.⁴ Williams, C.R.⁵ Xu, J.-L.⁶

7
- 84862827465
- http://www.medicinenet.com/ca-125/article.htm

8
- 0003432464
- American Cancer Society Atlanta
- American Cancer Society, Inc., Cancer Facts and Figures 2007 American Cancer Society Atlanta
- (2007) American Cancer Society, Inc., Cancer Facts and Figures

9
- 79958036419
- Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial
- S.S. Buys, E. Partridge, A. Black, C.C. Johnson, L. Lamerato, and C. Isaacs Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial JAMA 305 2011 2295 2303
- (2011) JAMA , vol.305 , pp. 2295-2303
- Buys, S.S.¹ Partridge, E.² Black, A.³ Johnson, C.C.⁴ Lamerato, L.⁵ Isaacs, C.⁶

10
- 67249153691
- Cumulative incidence of false-positive results in repeated, multimodal cancer screening
- J.M. Croswell, B.S. Kramer, A.R. Kreimer, P.C. Prorok, J.-L. Xu, and S.G. Baker Cumulative incidence of false-positive results in repeated, multimodal cancer screening Ann Family Med 7 2009 212 222
- (2009) Ann Family Med , vol.7 , pp. 212-222
- Croswell, J.M.¹ Kramer, B.S.² Kreimer, A.R.³ Prorok, P.C.⁴ Xu, J.-L.⁵ Baker, S.G.⁶

11
- 1542678929
- Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers
- S.J. Skates, D.K. Pauler, and I.J. Jacobs Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers J Am Stat Assoc 96 2001 429 439
- (2001) J Am Stat Assoc , vol.96 , pp. 429-439
- Skates, S.J.¹ Pauler, D.K.² Jacobs, I.J.³

12
- 0028829508
- Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers
- S.J. Skates, F.J. Xu, Y.H. Yu, K. Sjövall, N. Einhorn, and Y. Chang Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers Cancer 76 1995 2004 2010
- (1995) Cancer , vol.76 , pp. 2004-2010
- Skates, S.J.¹ Xu, F.J.² Yu, Y.H.³ Sjövall, K.⁴ Einhorn, N.⁵ Chang, Y.⁶

13
- 0030805956
- CA125 based diagnosis and therapy in recurrent ovarian cancer
- W. Meier, L. Baumgartner, P. Stieber, U. Hasholzner, and A. Fateh-Moghadam CA-125 based diagnosis and therapy in recurrent ovarian cancer Anticancer Res 17 1997 3019 3020 (Pubitemid 27434846)
- (1997) Anticancer Research , vol.17 , Issue.4 B , pp. 3019-3020
- Meier, W.¹ Baumgartner, L.² Stieber, P.³ Hasholzner, U.⁴ Fateh-Moghadam, A.⁵

14
- 0000084631
- The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
- The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial J.K. Gohagan, D.L. Levin, P.C. Prorok, and D. Sullivan Control clin trials 21(Suppl.) 2000 249S 406S
- (2000) Control Clin Trials , vol.21 SUPPL.
- Gohagan, J.K.¹ Levin, D.L.² Prorok, P.C.³ Sullivan, D.⁴

15
- 18044402499
- Design of the Prostate, Lung, Colon and Ovarian (PLCO) cancer screeing trial
- P.C. Prorok, G.L. Andriole, R.S. Bresalier, S.S. Buys, D. Chia, and E.D. Crawford Design of the Prostate, Lung, Colon and Ovarian (PLCO) cancer screeing trial Control Clin Trials 21 Suppl 2000 273S 309S
- (2000) Control Clin Trials , vol.21 , Issue.SUPPL
- Prorok, P.C.¹ Andriole, G.L.² Bresalier, R.S.³ Buys, S.S.⁴ Chia, D.⁵ Crawford, E.D.⁶

16
- 0003508724
- 2nd ed. John Wiley New York
- D.W. Hosmer, and S. Lemeshow Applied logistic regression 2nd ed. 2000 John Wiley New York
- (2000) Applied Logistic Regression
- Hosmer, D.W.¹ Lemeshow, S.²

17
- 0036833506
- A multivariate logistic regression equation to screen for diabetes: Development and validation
- DOI 10.2337/diacare.25.11.1999
- B.P. Tabaei, and W.H. Herman A multivariate logistic regression equation to screen for diabetes Diabetes Care 25 2002 1999 2003 (Pubitemid 41071058)
- (2002) Diabetes Care , vol.25 , Issue.11 , pp. 1999-2003
- Tabaei, B.P.¹ Herman, W.H.²

18
- 0036750477
- An introduction to logistic regression analysis and reporting
- C.-Y.J. Peng, K.L. Lee, and G.M. Ingersoll An introduction to logistic regression analysis and reporting J Educ Res 96 2002 3 14
- (2002) J Educ Res , vol.96 , pp. 3-14
- Peng, C.-Y.J.¹ Lee, K.L.² Ingersoll, G.M.³

19
- 0034906866
- Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis
- DOI 10.1016/S0895-4356(01)00341-9, PII S0895435601003419
- E.W. Steyerberg, F.E. Harrell Jr., G.J.J.M. Borsboom, M.J.C. Eijkemans, Y. Vergouwe, and J.D.F. Habbema Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774 781 (Pubitemid 32722180)
- (2001) Journal of Clinical Epidemiology , vol.54 , Issue.8 , pp. 774-781
- Steyerberg, E.W.¹ Harrell Jr., F.E.² Borsboom, G.J.J.M.³ Eijkemans, M.J.C.⁴ Vergouwe, Y.⁵ Habbema, J.D.F.⁶

20
- 0034728356
- What do we mean by validating a prognostic model?
- DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2- 5
- D.G. Altman, and P. Royston What do we mean by validating a prognostic model? Stat Med 19 2000 453 473 (Pubitemid 30126878)
- (2000) Statistics in Medicine , vol.19 , Issue.4 , pp. 453-473
- Altman, D.G.¹ Royston, P.²

21
- 0034732710
- Prognostic modelling with logistic regression analysis: A comparison of selection and estimation methods in small data sets
- DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0. CO;2-0
- E.W. Steyerberg, M.J.C. Eijkemans, and F.E. Harrell Jr. Habbema JDF: prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets Stat Med 19 2000 1059 1079 (Pubitemid 30238915)
- (2000) Statistics in Medicine , vol.19 , Issue.8 , pp. 1059-1079
- Steyerberg, E.W.¹ Eijkemans, M.J.C.² Harrell Jr., F.E.³ Habbema, J.D.F.⁴

22
- 0030069896
- Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
- DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2- 4
- F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387 (Pubitemid 26072233)
- (1996) Statistics in Medicine , vol.15 , Issue.4 , pp. 361-387
- Harrell Jr., F.E.¹ Lee, K.L.² Mark, D.B.³

23
- 0034731813
- Prognostic models based on literature and individual patient data in logistic regression analysis
- DOI 10.1002/(SICI)1097-0258(20000130)19:2<141::AID-SIM334>3.0.CO;2- O
- E.W. Steyerberg, M.J.C. Eijkemans, J.C. Houwelingen, K.L. Lee, and J.D. Habbema Prognosyic models based on literature and individual patient data in logistic regression analysis Stat Med 19 2000 141 160 (Pubitemid 30051239)
- (2000) Statistics in Medicine , vol.19 , Issue.2 , pp. 141-160
- Steyerberg, E.W.¹ Eijkemans, M.J.C.² Van Houwelingen, J.C.³ Lee, K.L.⁴ Habbema, J.D.F.⁵

24
- 0003463234
- Cambridge, U.K. Cambridge University Press
- M.H. Katz Multivariable analysis: a practical guide for clinicians 1999 Cambridge, U.K. Cambridge University Press
- (1999) Multivariable Analysis: A Practical Guide for Clinicians
- Katz, M.H.¹

25
- 34247162236
- Prostate-specific antigen velocity and prostate cancer gleason grade and stage
- DOI 10.1002/cncr.22558
- P.F. Pinsky, G. Andriole, E.D. Crawford, D. Chia, B.S. Kramer, and R. Grubb Prostate-specific antigen velocity and prostate cancer gleason grade and stage Cancer 109 2007 1689 1695 (Pubitemid 46595706)
- (2007) Cancer , vol.109 , Issue.8 , pp. 1689-1695
- Pinsky, P.F.¹ Andriole, G.² Crawford, E.D.³ Chia, D.⁴ Kramer, B.S.⁵ Grubb, R.⁶ Greenlee, R.⁷ Gohagan, J.K.⁸

26
- 84862790409
- Pre-biopsy prostate cancer nomograms based upon serial PSA screening data in the PLCO trial with verification bias correction
- G. Izmirlian, R.L. Grubb, A. Black, P.C. Prorok, C.D. Berg, and E.D. Crawford Pre-biopsy prostate cancer nomograms based upon serial PSA screening data in the PLCO trial with verification bias correction J Urol 181 Suppl 2009 609S-9S
- (2009) J Urol , vol.181 , Issue.SUPPL
- Izmirlian, G.¹ Grubb, R.L.² Black, A.³ Prorok, P.C.⁴ Berg, C.D.⁵ Crawford, E.D.⁶

27
- 84862810484
- http://seer.cancer.gov/faststats/selections.php

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.